“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...

The shot's efficacy declined slightly compared with the levels of protection after one RSV season, but the new data suggests that the jab generally offers durable protection for adults ages 60 and ...

RSV hospitalization rates in older adults reached 58.3 per 100,000 in winter 2023-24, nearly half the rate of influenza at 114.6 per 100,000. Mortality and clinical outcomes were comparable between ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study. The phase 3 randomized controlled trial ...

Learn how to identify RSV symptoms in adults, how to know if an RSV infection has become serious, how to avoid RSV, and whether to get an RSV vaccine.

A comprehensive new study reveals that respiratory syncytial virus (RSV) vaccines provide strong protection for adults aged 60 and older, with approximately 75% effectiveness against RSV-associated ...

Stephanie Mauro, now 76 years old, has had multiple sclerosis for more than 40 years. In 2020, when COVID-19 first appeared in the United States, her condition had worsened to the point where her pain ...

Respiratory syncytial virus prefusion F (RSVpreF) vaccine significantly reduced severe RSV-related lower respiratory tract disease (LRTD) requiring hospitalization or emergency department (ED) visits ...

Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

The UK Health Security Agency (UKHSA) has reported that the respiratory syncytial virus (RSV) vaccine is around 82% effective in preventing hospitalisation among adults aged 75-79. The data come from ...

The MarketWatch News Department was not involved in the creation of this content. -- Arexvy will account for the majority share of publicly funded RSV vaccine doses provided in the country for ...

Peak season ranges from late December to mid-February every year, the CDC website says. Last year in North Carolina, RSV ...